Patient characteristics associated with high-risk methotrexate concentrations and toxicity.
Mary V. Relling(St. Jude Children's Research Hospital), William E. Evans(St. Jude Children's Research Hospital), D. Ayers, John H. Rodman(St. Jude Children's Research Hospital), W R Crom, Diane Fairclough, Ching‐Hon Pui(St. Jude Children's Research Hospital)
Cited by 217
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Treatment of Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2006|2k
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
|Cancer Cell|2002|1.9k
Acute lymphoblastic leukaemia
|The Lancet|2008|1.6k